Works matching Diabetic cardiomyopathy
Results: 2512
血清硫氧还蛋白相互作用蛋白、Ⅲ型纤维蛋白结构域结合蛋白 5 与糖尿病性心肌病的相关性及诊断价值分析.
- Published in:
- Progress in Modern Biomedicine, 2023, v. 23, n. 14, p. 2683, doi. 10.13241/j.cnki.pmb.2023.14.015
- By:
- Publication type:
- Article
阿托伐他汀通过RGS6 改善糖尿病心肌病大鼠心功能的作用 及其机制研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 15, p. 2848, doi. 10.13241/j.cnki.pmb.2020.15.009
- By:
- Publication type:
- Article
MiR-146a 通过炎症参与小鼠糖尿病心肌病的机制研究.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 5, p. 848, doi. 10.13241/j.cnki.pmb.2020.05.010
- By:
- Publication type:
- Article
人参皂苷Rb1通过上调PGC-1α缓解糖尿病心肌病.
- Published in:
- Progress in Modern Biomedicine, 2020, v. 20, n. 1, p. 19, doi. 10.13241/j.cnki.pmb.2020.01.004
- By:
- Publication type:
- Article
Diabetic cardiomyopathy: Pathophysiological mechanisms and cardiac dysfuntion.
- Published in:
- Human & Experimental Toxicology, 2013, v. 32, n. 6, p. 571, doi. 10.1177/0960327112450885
- By:
- Publication type:
- Article
Empagliflozin ameliorates diabetic cardiomyopathy via regulated branched-chain amino acid metabolism and mTOR/p-ULK1 signaling pathway-mediated autophagy.
- Published in:
- Diabetology & Metabolic Syndrome, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13098-023-01061-6
- By:
- Publication type:
- Article
Ginsenoside Rg3 Protects against Diabetic Cardiomyopathy and Promotes Adiponectin Signaling via Activation of PPAR-γ.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16736, doi. 10.3390/ijms242316736
- By:
- Publication type:
- Article
mTORC1 and SGLT2 Inhibitors—A Therapeutic Perspective for Diabetic Cardiomyopathy.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15078, doi. 10.3390/ijms242015078
- By:
- Publication type:
- Article
The Mystery of Diabetic Cardiomyopathy: From Early Concepts and Underlying Mechanisms to Novel Therapeutic Possibilities.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 11, p. 5973, doi. 10.3390/ijms22115973
- By:
- Publication type:
- Article
Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 8, p. 2852, doi. 10.3390/ijms21082852
- By:
- Publication type:
- Article
Role of Oxidative Stress in Metabolic and Subcellular Abnormalities in Diabetic Cardiomyopathy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 7, p. 2413, doi. 10.3390/ijms21072413
- By:
- Publication type:
- Article
Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.
- Published in:
- 2021
- By:
- Publication type:
- Literature Review
Phenotyping diabetic cardiomyopathy in Europeans and South Asians.
- Published in:
- Cardiovascular Diabetology, 2019, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12933-019-0940-z
- By:
- Publication type:
- Article
Role of AIM2 Gene Knockdown Mechanism in Diabetic Cardiomyopathy: an In Vivo and Ex Vivo Study.
- Published in:
- Applied Biochemistry & Biotechnology, 2023, v. 195, n. 6, p. 3533, doi. 10.1007/s12010-022-04306-8
- By:
- Publication type:
- Article
Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression.
- Published in:
- Cardiovascular Drugs & Therapy, 2017, v. 31, n. 3, p. 255, doi. 10.1007/s10557-017-6732-3
- By:
- Publication type:
- Article
Never in mitosis gene A-related kinase-6 deficiency deteriorates diabetic cardiomyopathy via regulating heat shock protein 72.
- Published in:
- Journal of Molecular Medicine, 2023, v. 101, n. 4, p. 419, doi. 10.1007/s00109-023-02295-7
- By:
- Publication type:
- Article
Exercise enhances cardiac function by improving mitochondrial dysfunction and maintaining energy homoeostasis in the development of diabetic cardiomyopathy.
- Published in:
- Journal of Molecular Medicine, 2020, v. 98, n. 2, p. 245, doi. 10.1007/s00109-019-01861-2
- By:
- Publication type:
- Article
Demonstration of the Protective Effect of Vinpocetine in Diabetic Cardiomyopathy.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 16, p. 4637, doi. 10.3390/jcm13164637
- By:
- Publication type:
- Article
Adriamycin-induced cardiomyopathy can serve as a model for diabetic cardiomyopathy – a hypothesis.
- Published in:
- Asian Pacific Journal of Tropical Biomedicine, 2017, v. 7, n. 11, p. 1041, doi. 10.1016/j.apjtb.2017.09.021
- By:
- Publication type:
- Article
Defining the Progression of Diabetic Cardiomyopathy in a Mouse Model of Type 1 Diabetes.
- Published in:
- Frontiers in Physiology, 2020, p. 1, doi. 10.3389/fphys.2020.00124
- By:
- Publication type:
- Article
Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.983713
- By:
- Publication type:
- Article
Mitochondrial fusion promoter restores mitochondrial dynamics balance and ameliorates diabetic cardiomyopathy in an optic atrophy 1‐dependent way.
- Published in:
- Acta Physiologica, 2020, v. 229, n. 1, p. 1, doi. 10.1111/apha.13428
- By:
- Publication type:
- Article
Dual roles of myocardial mitochondrial AKT on diabetic cardiomyopathy and whole body metabolism.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02020-1
- By:
- Publication type:
- Article
Ca<sup>2+</sup> mishandling and mitochondrial dysfunction: a converging road to prediabetic and diabetic cardiomyopathy.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2022, v. 474, n. 1, p. 33, doi. 10.1007/s00424-021-02650-y
- By:
- Publication type:
- Article
Silencing lncRNA GAS5 alleviates apoptosis and fibrosis in diabetic cardiomyopathy by targeting miR-26a/b-5p.
- Published in:
- Acta Diabetologica, 2021, v. 58, n. 11, p. 1491, doi. 10.1007/s00592-021-01745-3
- By:
- Publication type:
- Article
Study on the mechanism of Astragalus in the treatment of diabetic cardiomyopathy based on network pharmacology and its preliminary verification study.
- Published in:
- Journal of Hainan Medical University, 2022, v. 28, n. 20, p. 23
- By:
- Publication type:
- Article
The relationship between Metrnl and diabetic cardiomyopathy and its related molecular mechanism.
- Published in:
- Journal of Hainan Medical University, 2022, v. 28, n. 9, p. 22
- By:
- Publication type:
- Article
Epicardial Adipose Tissue and Diabetic Cardiomyopathy.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2023, v. 28, p. 1, doi. 10.1177/10742484231151820
- By:
- Publication type:
- Article
口服中成药辅助治疗糖尿病心肌病的网状 Meta 分析.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2023, v. 23, n. 6, p. 723, doi. 10.14009/j.issn.1672-2124.2023.06.019
- By:
- Publication type:
- Article
Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 662, doi. 10.3390/biomedicines11030662
- By:
- Publication type:
- Article
NOX1 promotes myocardial fibrosis and cardiac dysfunction via activating the TLR2/NF-κB pathway in diabetic cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 01, doi. 10.3389/fphar.2022.928762
- By:
- Publication type:
- Article
Gut microbiota: A new therapeutic target for diabetic cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.963672
- By:
- Publication type:
- Article
Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.
- Published in:
- Frontiers in Endocrinology, 2024, p. 01, doi. 10.3389/fendo.2024.1185062
- By:
- Publication type:
- Article
Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1185062
- By:
- Publication type:
- Article
The role of exosomes and exosomal microRNA in diabetic cardiomyopathy.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2023.1327495
- By:
- Publication type:
- Article
Epigenetics of methylation modifications in diabetic cardiomyopathy.
- Published in:
- Frontiers in Endocrinology, 2023, v. 14, p. 1, doi. 10.3389/fendo.2023.1119765
- By:
- Publication type:
- Article
Ginger Extract and Omega-3 Fatty Acids Supplementation: A Promising Strategy to Improve Diabetic Cardiomyopathy.
- Published in:
- Physiological Research, 2024, v. 73, n. 3, p. 351, doi. 10.33549/physiolres.935266
- By:
- Publication type:
- Article
Fucoidan from Sargassum wightii reduces oxidative stress through upregulating Nrf2/HO-1 signaling pathway in alloxan-induced diabetic cardiomyopathy rats.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 11, p. 8855, doi. 10.1007/s11033-023-08780-z
- By:
- Publication type:
- Article
Type I Diabetic Akita Mouse Model is Characterized by Abnormal Cardiac Deformation During Early Stages of Diabetic Cardiomyopathy with Speckle-Tracking Based Strain Imaging.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2018, v. 45, n. 4, p. 1541, doi. 10.1159/000487690
- By:
- Publication type:
- Article
The Sodium-Glucose Co-Transporter 2 Inhibitor, Empaglifozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 41, n. 6, p. 2503, doi. 10.1159/000475942
- By:
- Publication type:
- Article
Carvedilol alleviates diabetic cardiomyopathy in diabetic rats.
- Published in:
- Experimental & Therapeutic Medicine, 2019, v. 17, n. 1, p. 479
- By:
- Publication type:
- Article
LncRNA HOTAIR improves diabetic cardiomyopathy by increasing viability of cardiomyocytes through activation of the PI3K/Akt pathway.
- Published in:
- Experimental & Therapeutic Medicine, 2018, v. 16, n. 6, p. 4817, doi. 10.3892/etm.2018.6755
- By:
- Publication type:
- Article
Oleanolic acid protects against diabetic cardiomyopathy via modulation of the nuclear factor erythroid 2 and insulin signaling pathways.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 1, p. 848, doi. 10.3892/etm.2017.4527
- By:
- Publication type:
- Article
Reduced Fatty Acid Use from CD36 Deficiency Deteriorates Streptozotocin-Induced Diabetic Cardiomyopathy in Mice.
- Published in:
- Metabolites (2218-1989), 2021, v. 11, n. 12, p. 881, doi. 10.3390/metabo11120881
- By:
- Publication type:
- Article
The Role of Renin–Angiotensin System in Diabetic Cardiomyopathy: A Narrative Review.
- Published in:
- Life (2075-1729), 2023, v. 13, n. 7, p. 1598, doi. 10.3390/life13071598
- By:
- Publication type:
- Article
Scintigrafie u diabetické kardiomyopatie.
- Published in:
- Nuclear Medicine / Nukleární Medicína, 2013, v. 2, n. 4, p. 62
- By:
- Publication type:
- Article
Bone Morphogenetic Protein 7 Gene Delivery Improves Cardiac Structure and Function in a Murine Model of Diabetic Cardiomyopathy.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.719290
- By:
- Publication type:
- Article
Senescence and Type 2 Diabetic Cardiomyopathy: How Young Can You Die of Old Age?
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.716517
- By:
- Publication type:
- Article
Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.683335
- By:
- Publication type:
- Article
Pyridostigmine Protects Against Diabetic Cardiomyopathy by Regulating Vagal Activity, Gut Microbiota, and Branched-Chain Amino Acid Catabolism in Diabetic Mice.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.647481
- By:
- Publication type:
- Article